Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Non-Hodgkin's Lymphoma
Both
Non-Hodgkin's Lymphoma
Trial Information
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma
The first primary objective reflects a necessary and preliminary requirement: to reproduce
published results and validate the use of FLT-PET. In this study, 35 patients will be
selected to undergoing imaging with both FLT and FDG PET.
Inclusion Criteria:
- 18 years or older
- Women must not be pregnant or breast feeding
- Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
- Must undergo treatment with chemotherapy and/or radiotherapy
Exclusion Criteria:
- May not have received previous therapy with radiopharmaceuticals
- May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal
antibodies
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Staging and ReStaging scans
Outcome Time Frame:
after hematopoetic recovery
Safety Issue:
No
Authority:
United States: Food and Drug Administration
Study ID:
FLT-NHL
NCT ID:
NCT00775957
Start Date:
October 2008
Completion Date:
Related Keywords:
- Non-Hodgkin's Lymphoma
- Lymphoma
- Lymphoma, Non-Hodgkin
Name | Location |
|---|---|
| University of Oklahoma Health Sciences Center | Oklahoma City, Oklahoma 73104 |
